Clinical investigation of bronchioloalveolar carcinoma: A retrospective analysis of 53 patients in a single institution

Nobukazu Fujimoto; Yoshihiko Segawa; Nagio Takigawa; Katsuyuki Hotta; Daizo Kishino; Michihide Shimono; Masao Nakata; Hideyuki Saeki; Koichi Mandai; Kenji Eguch

Clinical investigation of bronchioloalveolar carcinoma: A retrospective analysis of 53 patients in a single institution

Nobukazu Fujimoto, Yoshihiko Segawa, Nagio Takigawa, Katsuyuki Hotta, Daizo Kishino, Michihide Shimono, Masao Nakata, Hideyuki Saeki, Koichi Mandai, Kenji Eguch

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Abstract

Background. Bronchioloalveolar carcinoma (BAC) has been reported to have unique clinicopathological features. Patients and Methods. This retrospective study was performed using data base including 871 patients treated for primary lung cancer between 1981 and 1995. Results; The patients with BAC included a larger proportion of female (P = 0.029) and smoked less (P = 0.002) than those with non-BAC. There was no difference in survival between surgically resected patients with BAC and those with non-BAC. Clinical Stage IV patients with BAC had a better response to chemotherapy than did those with non-BAC. Survival in the former group was better than that in the latter on univariate analysis, but the significance of this difference was not confirmed multivariate analysis. Conclusion; The patients with BAC included a larger proportion of females and smoked less than those with non-BAC. Treatment results for BAC was comparable to those for non-BAC.

Original language	English
Pages (from-to)	1369-1373
Number of pages	5
Journal	Anticancer research
Volume	19
Issue number	2 B
Publication status	Published - Jun 14 1999
Externally published	Yes

Keywords

Adenocarcinoma of the lung
Bronchioloalveolar carcinoma
Chemosensitivity
Surgical resection

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Clinical investigation of bronchioloalveolar carcinoma : A retrospective analysis of 53 patients in a single institution. / Fujimoto, Nobukazu; Segawa, Yoshihiko; Takigawa, Nagio; Hotta, Katsuyuki; Kishino, Daizo; Shimono, Michihide; Nakata, Masao; Saeki, Hideyuki; Mandai, Koichi; Eguch, Kenji.

In: Anticancer research, Vol. 19, No. 2 B, 14.06.1999, p. 1369-1373.

Research output: Contribution to journal › Article › peer-review

Fujimoto, Nobukazu ; Segawa, Yoshihiko ; Takigawa, Nagio ; Hotta, Katsuyuki ; Kishino, Daizo ; Shimono, Michihide ; Nakata, Masao ; Saeki, Hideyuki ; Mandai, Koichi ; Eguch, Kenji. / Clinical investigation of bronchioloalveolar carcinoma : A retrospective analysis of 53 patients in a single institution. In: Anticancer research. 1999 ; Vol. 19, No. 2 B. pp. 1369-1373.

@article{bdee68e71cb146408928a5884bde755d,

title = "Clinical investigation of bronchioloalveolar carcinoma: A retrospective analysis of 53 patients in a single institution",

abstract = "Background. Bronchioloalveolar carcinoma (BAC) has been reported to have unique clinicopathological features. Patients and Methods. This retrospective study was performed using data base including 871 patients treated for primary lung cancer between 1981 and 1995. Results; The patients with BAC included a larger proportion of female (P = 0.029) and smoked less (P = 0.002) than those with non-BAC. There was no difference in survival between surgically resected patients with BAC and those with non-BAC. Clinical Stage IV patients with BAC had a better response to chemotherapy than did those with non-BAC. Survival in the former group was better than that in the latter on univariate analysis, but the significance of this difference was not confirmed multivariate analysis. Conclusion; The patients with BAC included a larger proportion of females and smoked less than those with non-BAC. Treatment results for BAC was comparable to those for non-BAC.",

keywords = "Adenocarcinoma of the lung, Bronchioloalveolar carcinoma, Chemosensitivity, Surgical resection",

author = "Nobukazu Fujimoto and Yoshihiko Segawa and Nagio Takigawa and Katsuyuki Hotta and Daizo Kishino and Michihide Shimono and Masao Nakata and Hideyuki Saeki and Koichi Mandai and Kenji Eguch",

year = "1999",

month = jun,

day = "14",

language = "English",

volume = "19",

pages = "1369--1373",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "2 B",

}

TY - JOUR

T1 - Clinical investigation of bronchioloalveolar carcinoma

T2 - A retrospective analysis of 53 patients in a single institution

AU - Fujimoto, Nobukazu

AU - Segawa, Yoshihiko

AU - Takigawa, Nagio

AU - Hotta, Katsuyuki

AU - Kishino, Daizo

AU - Shimono, Michihide

AU - Nakata, Masao

AU - Saeki, Hideyuki

AU - Mandai, Koichi

AU - Eguch, Kenji

PY - 1999/6/14

Y1 - 1999/6/14

N2 - Background. Bronchioloalveolar carcinoma (BAC) has been reported to have unique clinicopathological features. Patients and Methods. This retrospective study was performed using data base including 871 patients treated for primary lung cancer between 1981 and 1995. Results; The patients with BAC included a larger proportion of female (P = 0.029) and smoked less (P = 0.002) than those with non-BAC. There was no difference in survival between surgically resected patients with BAC and those with non-BAC. Clinical Stage IV patients with BAC had a better response to chemotherapy than did those with non-BAC. Survival in the former group was better than that in the latter on univariate analysis, but the significance of this difference was not confirmed multivariate analysis. Conclusion; The patients with BAC included a larger proportion of females and smoked less than those with non-BAC. Treatment results for BAC was comparable to those for non-BAC.

AB - Background. Bronchioloalveolar carcinoma (BAC) has been reported to have unique clinicopathological features. Patients and Methods. This retrospective study was performed using data base including 871 patients treated for primary lung cancer between 1981 and 1995. Results; The patients with BAC included a larger proportion of female (P = 0.029) and smoked less (P = 0.002) than those with non-BAC. There was no difference in survival between surgically resected patients with BAC and those with non-BAC. Clinical Stage IV patients with BAC had a better response to chemotherapy than did those with non-BAC. Survival in the former group was better than that in the latter on univariate analysis, but the significance of this difference was not confirmed multivariate analysis. Conclusion; The patients with BAC included a larger proportion of females and smoked less than those with non-BAC. Treatment results for BAC was comparable to those for non-BAC.

KW - Adenocarcinoma of the lung

KW - Bronchioloalveolar carcinoma

KW - Chemosensitivity

KW - Surgical resection

UR - http://www.scopus.com/inward/record.url?scp=0032994008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032994008&partnerID=8YFLogxK

M3 - Article

C2 - 10365108

AN - SCOPUS:0032994008

VL - 19

SP - 1369

EP - 1373

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 B

ER -

Clinical investigation of bronchioloalveolar carcinoma: A retrospective analysis of 53 patients in a single institution

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this